Supernus Pharmaceuticals: Peers

The FY2025 (Dec) proxy of Supernus Pharmaceuticals names 16 peer companies for pay. Among Supernus Pharmaceuticals and these peers, CEO pay was 2nd highest of 5 and total shareholder return was the highest of 5.

2nd highest of 5in Supernus Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:

$7.9M$23.3M

1st highest of 5in Supernus Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:

$17$198

Pay peer group, FY2025 (Dec) proxy

PTC Therapeutics
Ultragenyx Pharmaceutical
Alkermes plc.
Harmony Biosciences Holdings
Acadia PharmaceuticalsNot disclosedNot disclosed
Ani PharmaceuticalsNot disclosedNot disclosed
Amicus Therapeutics, Inc.Not disclosedNot disclosed
Amphastar Pharmaceuticals, Inc.Not disclosedNot disclosed
Axsome TherapeuticsNot disclosedNot disclosed
Catalyst Pharmaceuticals, Inc.Not disclosedNot disclosed
Collegium Pharmaceutical, Inc.Not disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Dynavax Technologies CorporationNot disclosedNot disclosed
Ligand PharmaceuticalsNot disclosedNot disclosed
Pacira Biosciences, Inc.Not disclosedNot disclosed
Xeris Biopharma Holdings, Inc.Not disclosedNot disclosed
16 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.